Cancer IQ Inc.

CIK 1810038 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cancer IQ Inc..

Recent SEC filings

FiledFormAccession number
May 26, 2026D/A0001810038-26-000003
Nov 13, 2023D0001810038-23-000001
Apr 8, 2022D0001810038-22-000005
Apr 23, 2020D0000897069-20-000196